Last $0.39 USD
Change Today +0.0101 / 2.66%
Volume 400.0
VIVMF On Other Exchanges
Symbol
Exchange
OTC US
As of 9:41 AM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

viveve medical inc (VIVMF) Snapshot

Open
$0.39
Previous Close
$0.38
Day High
$0.39
Day Low
$0.39
52 Week High
03/7/14 - $4.81
52 Week Low
11/13/14 - $0.35
Market Cap
7.0M
Average Volume 10 Days
1.9K
EPS TTM
$0.48
Shares Outstanding
18.0M
EX-Date
--
P/E TM
0.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for VIVEVE MEDICAL INC (VIVMF)

Related News

No related news articles were found.

viveve medical inc (VIVMF) Related Businessweek News

No Related Businessweek News Found

viveve medical inc (VIVMF) Details

Viveve Medical, Inc., through its subsidiary, Viveve, Inc., designs, develops, manufactures, and markets medical devices for the treatment of vaginal introital laxity. It provides Viveve system, a non-ablative medical device to treat the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth. The company markets its products through sales consultants and distribution partners in Canada, Hong Kong, and Japan. Viveve Medical, Inc. was founded in 2005 and is headquartered in Sunnyvale, California.

6 Employees
Last Reported Date: 02/18/15
Founded in 2005

viveve medical inc (VIVMF) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $335.0K
Chief Financial Officer
Total Annual Compensation: $348.0K
Vice President of Regulatory, Clinical & Qual...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2014.

viveve medical inc (VIVMF) Key Developments

Viveve Announces Distribution Partnership with CoachHouse Medical in the United Kingdom

Viveve Medical, Inc. announced a new distribution partnership with CoachHouse Medical. This partnership combines Viveve's innovative product for treating vaginal laxity with CoachHouse's expertise in building new medical device markets throughout the United Kingdom.

Viveve Medical, Inc. Appoints James Atkinson as Chief Business Officer and President

Viveve Medical, Inc. announced that James Atkinson has joined the company as Chief Business Officer and President. In this newly created position, Mr. Atkinson will provide strategic leadership in building the company's global distribution network, positioning Viveve for strong market expansion worldwide. In addition, he will serve as a member of Viveve's executive leadership team where he will contribute to the formulation and execution of the company's strategic vision. Prior to joining the company as Chief Business Officer and President, Jim was the Senior Vice President of Global Sales at Ulthera, Inc. through April, 2014.

Viveve Medical, Inc. Presents at Retail Investor Conference, Dec-04-2014 10:00 AM

Viveve Medical, Inc. Presents at Retail Investor Conference, Dec-04-2014 10:00 AM. Speakers: Patricia K. Scheller, Chief Executive Officer and Director, Scott C. Durbin, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIVMF:US $0.39 USD +0.0101

VIVMF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VIVMF.
View Industry Companies
 

Industry Analysis

VIVMF

Industry Average

Valuation VIVMF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.0x
Price/Book 10.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 63.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVEVE MEDICAL INC, please visit www.viveve.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.